Skip to main content
Log in

Screening, case finding or primary cancer prevention in the developing world?

  • COMMENTARY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boyle P, Levin B, editors. World Cancer Report 2008. Lyon: International Agency for Research on Cancer (IARC); 2008.

    Google Scholar 

  2. Smith RA, Caleffi M, Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006;12(Suppl 1):S16–26. doi:10.1111/j.1075-122X.2006.00200.x.

    Article  PubMed  Google Scholar 

  3. Ifere GO, Abebe F, Ananaba GA. Emergent trends in the reported incidence of prostate cancer in Nigeria. Clin Epidemiol. 2012;4:19–32. doi:10.2147/CLEP.S23536.

    PubMed  Google Scholar 

  4. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010;376(9747):1186–93. doi:10.1016/S0140-6736(10)61152-X.

    Article  PubMed  Google Scholar 

  5. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203–10. doi:10.1056/NEJMoa1000727.

    Article  PubMed  CAS  Google Scholar 

  6. Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ. 2010;340:c1241.

    Article  PubMed  Google Scholar 

  7. Gotzsche PC, Jorgensen KJ, Zahl PH, Maehlen J. Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control. 2012;23(1):15–21. doi:10.1007/s10552-011-9867-8.

    Article  PubMed  Google Scholar 

  8. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605–13. doi:10.1093/jnci/djq099.

    Article  PubMed  Google Scholar 

  9. Adami HO. The prostate cancer pseudo-epidemic. Acta Oncol. 2010;49(3):298–304. doi:10.3109/02841860903584945.

    Article  PubMed  Google Scholar 

  10. Loeb S, Vonesh EF, Metter EJ, Carter HB, Gann PH, Catalona WJ. What is the true number needed to screen and treat to save a life with prostate-specific antigen testing? J Clin Oncol. 2011;29(4):464–7. doi:10.1200/JCO.2010.30.6373.

    Article  PubMed  Google Scholar 

  11. Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann intern med. 2011;155(11):762–71. doi:10.1059/0003-4819-155-11-201112060-00375.

  12. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2000;21(6 Suppl):273S–309S.

    Article  PubMed  CAS  Google Scholar 

  13. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993;328(19):1365–71. doi:10.1056/NEJM199305133281901.

    Article  PubMed  CAS  Google Scholar 

  14. Bretthauer M, Kalager M. Colonoscopy as a triage screening test. N Engl J Med. 2012;366(8):759–60. doi:10.1056/NEJMe1114639.

    Article  PubMed  CAS  Google Scholar 

  15. Clarke EA, Anderson TW. Does screening by “Pap” smears help prevent cervical cancer? A case-control study. Lancet. 1979;2(8132):1–4.

    Article  PubMed  CAS  Google Scholar 

  16. Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997;8(5):755–63.

    Article  PubMed  CAS  Google Scholar 

  17. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784–93.

    Article  PubMed  Google Scholar 

  18. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.

    Article  PubMed  Google Scholar 

  19. Chokshi DA, Farley TA. The cost-effectiveness of environmental approaches to disease prevention. N Engl J Med. 2012;367(4):295–7. doi:10.1056/NEJMp1206268.

    Article  PubMed  CAS  Google Scholar 

  20. Whitby LG. Screening for disease: definitions and criteria. Lancet. 1974;2(7884):819–22.

    Article  PubMed  CAS  Google Scholar 

  21. Ponten J, Adami HO, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer. 1995;60(1):1–26.

    Article  PubMed  CAS  Google Scholar 

  22. Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;. doi:10.1002/cncr.27410.

    Google Scholar 

Download references

Acknowledgments

We thank Dr Michelle Holmes at Harvard School of Public Health, Harvard University, and Dr Jacob Holmqvist, at Karlstad Central Hospital, Karlstad, Sweden for their comments on an earlier draft of this report. No specific funding was acquired, but Dr Gustaf Edgren is supported by a postdoctoral grant from Svenska Sällskapet för Medicinsk Forskning (SSMF).

Conflict of interest

We declare we have no relevant conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gustaf Edgren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edgren, G., Lagiou, P., Trichopoulos, D. et al. Screening, case finding or primary cancer prevention in the developing world?. Eur J Epidemiol 28, 287–290 (2013). https://doi.org/10.1007/s10654-013-9788-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-013-9788-9

Keywords

Navigation